|
Volumn 36, Issue 16, 2000, Pages 2096-2104
|
Information and communication in the context of a clinical trial
|
Author keywords
Clinical trial; Communication; Information; Randomisation; Sociodemographics
|
Indexed keywords
TAMOXIFEN;
TOREMIFENE;
ADJUVANT THERAPY;
ADULT;
AGED;
ARTICLE;
BREAST CANCER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DECISION MAKING;
FEMALE;
HUMAN;
INTERPERSONAL COMMUNICATION;
MAJOR CLINICAL STUDY;
PATIENT EDUCATION;
PATIENT INFORMATION;
PRIORITY JOURNAL;
PSYCHOLOGICAL ASPECT;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
EMPIRICAL APPROACH;
ADULT;
AGED;
AWARENESS;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
COMMUNICATION;
DECISION MAKING;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MIDDLE AGED;
PATIENT EDUCATION;
PATIENT PARTICIPATION;
PATIENT SATISFACTION;
PHYSICIAN-PATIENT RELATIONS;
QUESTIONNAIRES;
RANDOMIZED CONTROLLED TRIALS;
|
EID: 0033816160
PISSN: 09598049
EISSN: None
Source Type: Journal
DOI: 10.1016/S0959-8049(00)00191-X Document Type: Article |
Times cited : (74)
|
References (29)
|